Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50
更正:真实世界多中心队列研究,评估一线帕博利珠单抗单药或联合铂类化疗治疗PD-L1≥50的非小细胞肺癌的效果
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-023-03405-7
Pons-Tostivint, E; Hulo, P; Guardiolle, V; Bodot, L; Rabeau, A; Porte, M; Hiret, S; Demontrond, P; Curcio, H; Boudoussier, A; Veillon, R; Mayenga, M; Dumenil, C; Chatellier, T; Gourraud, P A; Mazieres, J; Bennouna, J